A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment.

Passamonti, F; Thiele, J; Girodon, F; Rumi, E; Carobbio, A; Gisslinger, H; Kvasnicka, Hm; Ruggeri, M; Randi, Ml; Gangat, N; Vannucchi, ALESSANDRO MARIA; Gianatti, A; Gisslinger, B; Müllauer, L; Rodeghiero, F; D'Amore, Es; Bertozzi, I; Hanson, Ca; Boveri, E; Marino, F; Maffioli, M; Caramazza, D; Antonioli, E; Carrai, V; Buxhofer Ausch, V; Pascutto, C; Cazzola, M; Barbui, T; Tefferi, A.

doi:10.1182/blood-2012-01-403279

sviluppo di un modello prognostico per la sopravvivenza in apzienti con trombocitemia essenziale

A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment / Passamonti F;Thiele J;Girodon F;Rumi E;Carobbio A;Gisslinger H;Kvasnicka HM;Ruggeri M;Randi ML;Gangat N;Vannucchi AM;Gianatti A;Gisslinger B;Müllauer L;Rodeghiero F;d'Amore ES;Bertozzi I;Hanson CA;Boveri E;Marino F;Maffioli M;Caramazza D;Antonioli E;Carrai V;Buxhofer-Ausch V;Pascutto C;Cazzola M;Barbui T;Tefferi A. - In: BLOOD. - ISSN 0006-4971. - STAMPA. - 120:(2012), pp. 1197-1201. [10.1182/blood-2012-01-403279]